Текущие обязательства Изменить Дата
Agilent USD 2.29B 20M 2026-06
Align Technology USD 1.91B 4.9M 2026-09
Bio Techne USD 163.7M 10.42M 2026-06
Bio-Rad Laboratories USD 969.1M 7.8M 2026-09
Bruker USD 1.2B 150.4M 2026-06
Celltrion KRW 288.01B 4.7B 2026-06
Charles River Laboratories USD 1.09B 45.49M 2026-09
Cspc Pharmaceutical CNY 10.18B 65.36M 2025-12
Danaher USD 9.05B 945M 2026-09
Dentsply International USD 1.18B 22M 2026-06
Deva Holding AS TRY 6.43B 1.18B 2023-09
Dianthus Therapeutics USD 28.51M 5.87M 2026-09
Divis Laboratories Ltd INR 20.43B 3.15B 2026-03
Edwards Lifesciences USD 1.58B 68.8M 2026-09
Illumina USD 1.16B 422M 2026-09
Intuitive Surgical USD 3.23B 652.4M 2026-09
IQVIA Holdings USD 7.78B 1.04B 2026-09
Kangmei Pharma CNY 5.1B 280.48M 2026-06
Knight Therapeutics CAD 165.26M 12.58M 2025-12
Laboratorios Farma EUR 199.84M 121.75M 2023-12
Laboratory Of America USD 2.82B 695M 2026-09
Malin Corporation EUR 1000K 500K 2024-12
Medical Developments International AUD 5.56M 2.26M 2025-12
Mesa Laboratories USD 54.4M 6.1M 2025-12
Mettler Toledo International USD 1.2B 92.14M 2026-06
Myriad Genetics USD 130.7M 500K 2026-06
Neuren Pharmaceuticals AUD 4.34M 3.58M 2025-12
OraSure Technologies USD 25.12M 18.96M 2026-06
Organigram Holdings CAD 107.28M 18.54M 2026-06
Ovoca Bio EUR 1.3M 1.11M 2025-12
Pacific Biosciences Of California USD 68.81M 3.45M 2026-06
Pharma Mar EUR 125.39M 26.97M 2026-09
Qiagen NV USD 581.45M 102.34M 2026-06
Quest Diagnostics USD 1.83B 46M 2026-09
Quidel USD 1.07B 73.7M 2026-09
Repligen USD 125.69M 6.97M 2026-09
Revvity USD 701.48M 574.88M 2026-09
Sartorius EUR 1.55B 102.8M 2026-09
Sino Biopharmaceutical CNY 24.85B 5.29B 2025-06
Thermo Fisher Scientific USD 14.17B 899M 2026-09
Tilray USD 259.32M 8.32M 2025-09
Waters USD 2.4B 126M 2026-06
Zealand Pharma A/S 404M 260.96M 2026-03
Zz Pientze Pharmaceu CNY 2.74B 277.02M 2026-09